Skip to main content

Seoul Cosmetic Surgery Clinic Expands K-Beauty PRP & PRF Facial Treatments

Lydian Cosmetic Surgery Clinic in Seoul is expanding its regenerative medicine services for international patients, offering treatments similar to those celebrity Kim Kardashian is reported to have received when she visited a South Korean clinic earlier this year.

-- The recent expansion from Lydian Cosmetic Surgery Clinic addresses increasing international demand for K-Beauty treatments, which focus on proactive approaches to aesthetics rather than correction. As South Korea becomes a global destination for beauty services, the Lydian Cosmetic Surgery Clinic has broadened its coordination services for medical tourism.

Interested parties can learn more at https://www.lydianclinic.com/blog/kim-kardashian-prp-prf-treatment-korea/

In recent years, Korea has become a recognized center for combining regenerative medicine with aesthetic treatments, attracting clients from around the world. This includes celebrity Kim Kardashian, who shared photos she took undergoing treatments at a Seoul clinic on social media earlier this year. While Kardashian has declined to disclose which procedures she received, experts have analyzed the pictures and concluded she may have received platelet-rich plasma (PRP) facial treatments and stem cell therapy, as well as laser and resurfacing treatments.

Public interest in these procedures has increased significantly following Kardashian's visit to Korea, industry officials report. In response, Lydian Cosmetic Surgery Clinic's expanded coordination assistance and bilingual services provide access to cutting-edge, clinical K-Beauty procedures.

Lydian Clinic's team explains that their stem cell treatment method uses CGP bone marrow stem cell extraction, which is reported to produce higher stem cell concentrations per sample compared to blood-derived stem cells. This method may enable faster cellular regeneration and more visible outcomes, with patients observing brighter, more radiant skin within one to two weeks. Improvements in elasticity, accelerated healing, and enhanced immune function become evident over three to six months.

Korean facilities operate under regulatory oversight and use extraction methods designed to yield higher stem cell concentrations than conventional approaches. Equipment used in the program carries approval from Korea's Ministry of Health and Welfare and KFDA (Korea's equivalent to the FDA), and the clinic employs full-time anesthesiologists alongside in-house clinical pathologists who conduct pre-treatment medical evaluations.

Located in Seoul's Gangnam district, the Lydian Clinic has completed more than 20,000 treatments during its 23-year history. Its chief director, Dr. Abraham An, has been named one of the top stem cell therapy experts in the world.

For more information, please visit https://www.lydianclinic.com/stemcelleng

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Source: NewsNetwork

Release ID: 89178663

If there are any errors, inconsistencies, or queries arising from the content contained within this press release that require attention or if you need assistance with a press release takedown, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our reliable team will be available to promptly respond within 8 hours, taking proactive measures to rectify any identified issues or providing guidance on the removal process. Ensuring accurate and dependable information is our top priority.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.19
-4.09 (-1.78%)
AAPL  278.28
+0.25 (0.09%)
AMD  210.78
-10.65 (-4.81%)
BAC  55.14
+0.58 (1.06%)
GOOG  310.52
-3.18 (-1.01%)
META  644.23
-8.48 (-1.30%)
MSFT  478.53
-4.94 (-1.02%)
NVDA  175.02
-5.91 (-3.27%)
ORCL  189.97
-8.88 (-4.47%)
TSLA  458.96
+12.07 (2.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.